ZYME Q3 2021 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+66.3% YoY

Gross Profit

-$45M-1035.2% margin

Operating Income

-$61M-1387.1% margin

Net Income

-$61M-1378.4% margin

EPS (Diluted)

$-1.16

QoQ Revenue Growth

+148.2%

Cash Flow

Operating Cash Flow

-$51M

Free Cash Flow

-$56M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$420M

Total Liabilities

$141M

Stockholders' Equity

$279M

Cash & Equivalents

$253M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$3M	+66.3%
Gross Profit	-$45M	-$52M	+12.1%
Operating Income	-$61M	-$74M	+17.3%
Net Income	-$61M	-$73M	+16.5%

Revenue Segments

Performance Milestone

$4M91%

Other Product

$395,0009%